Raymond James Reiterates Strong Buy Rating on Liquidia Technologies (LQDA)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to Raymond James Reiterates Strong Buy Rating on Liquidia Technologies (LQDA)

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ Patent

October 7, 2024 10:00 AM EDT

U.S. Supreme Court denied United Therapeutics petition to appeal rulings that found all claims of U.S. Patent No. 10,716,793 (793 Patent) were invalidDecisions that Liquidia does not infringe any valid claims of the three patents originally asserted by United Therapeutics are now final and not subject to further appeal

MORRISVILLE, N.C., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a... More